Article
Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
Journal of virological methods - 1 Oct 2018
Pestana Cristiane Pinheiro, Lawson-Ferreira Rafael, Lessa-Aquino Carolina, Leal Maria da Luz Fernandes, Freire Marcos da Silva, Homma Akira, Medeiros Marco Alberto
Abstract excerpt
Yellow Fever (YF) is an acute viral hemorrhagic disease prevalent mainly in Africa and Americas, with 20-60% fatality rate in severe forms. Currently, antiviral drugs for the infection are not available, reinforcing the importance of vaccination in resident populations and travelers. Manufactured in 7 different countries, the YF vaccine was first created in 1937 and two substrains are used for production, 17DD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
